Artículos por temáticas

Neuroprotective and Neurotoxic Implications of α7 Nicotinic Acetylcholine Receptor and Aβ Interaction: Therapeutic Options in Alzheimer's Disease

Farhat SM, Ahmed T.

Curr Drug Targets. 2017;18(13):1537-1544. doi: 10.2174/1389450117666161005145143.

Association of Serum Manganese Levels with  Alzheimer's Disease and Mild Cognitive Impairment:  A Systematic Review and Meta-Analysis

Du K, Liu M, Pan Y, Zhong X, Wei M.

Nutrients. 2017 Mar 3;9(3):231. doi: 10.3390/nu9030231.

Amylin and its G-protein-coupled receptor: A probable pathological process and drug target for Alzheimer's disease

Qiu WQ.

Neuroscience. 2017 Jul 25;356:44-51. doi: 10.1016/j.neuroscience.2017.05.024. Epub 2017 May 19.

Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer's disease

Kim SH, Kandiah N, Hsu JL, Suthisisang C, Udommongkol C, Dash A.

Br J Pharmacol. 2017 Dec;174(23):4224-4232. doi: 10.1111/bph.14030. Epub 2017 Oct 29.

Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation

Mohammad D, Chan P, Bradley J, Lanctôt K, Herrmann N.

Expert Opin Drug Saf. 2017 Sep;16(9):1009-1019. doi: 10.1080/14740338.2017.1351540. Epub 2017 Jul 12.

Chinese herbal medicine for Alzheimer's disease: Clinical evidence and possible mechanism of neurogenesis

Yang WT, Zheng XW, Chen S, Shan CS, Xu QQ, Zhu JZ, Bao XY, Lin Y, Zheng GQ, Wang Y.

Biochem Pharmacol. 2017 Oct 1;141:143-155. doi: 10.1016/j.bcp.2017.07.002. Epub 2017 Jul 8.

Exploration of Various Proteins for the Treatment of Alzheimer's Disease

Islam BU, Zaidi SK, Kamal MA, Tabrez S.

Curr Drug Metab. 2017;18(9):808-813. doi: 10.2174/1389200218666170203110135.

Bapineuzumab for mild to moderate Alzheimer's disease: a meta-analysis of randomized controlled trials

Abushouk AI, Elmaraezy A, Aglan A, Salama R, Fouda S, Fouda R, AlSafadi AM.

BMC Neurol. 2017 Apr 4;17(1):66. doi: 10.1186/s12883-017-0850-1.

Acute renal failure caused by cilostazol in a patient with Alzheimer's disease

Nomoto H, Matsubara Y, Ichimiya Y, Arai H.

Geriatr Gerontol Int. 2017 Jan;17(1):171-172. doi: 10.1111/ggi.12760.

Rheumatoid arthritis and risk for Alzheimer's disease: a systematic review and meta-analysis and a Mendelian Randomization study

Policicchio S, Ahmad AN, Powell JF, Proitsi P.

Sci Rep. 2017 Oct 9;7(1):12861. doi: 10.1038/s41598-017-13168-8.

Microglia-Synapse Pathways: Promising Therapeutic Strategy for Alzheimer's Disease

Xie J, Wang H, Lin T, Bi B.

Biomed Res Int. 2017;2017:2986460. doi: 10.1155/2017/2986460. Epub 2017 Apr 3.

Cholinergic symptoms and QTc prolongation following donepezil overdose

Pourmand A, Shay C, Redha W, Aalam A, Mazer-Amirshahi M.

Am J Emerg Med. 2017 Sep;35(9):1386.e1-1386.e3. doi: 10.1016/j.ajem.2017.06.044. Epub 2017 Jun 22.

Current opinion in Alzheimer's disease therapy by nanotechnology-based approaches

Ansari SA, Satar R, Perveen A, Ashraf GM.

Curr Opin Psychiatry. 2017 Mar;30(2):128-135. doi: 10.1097/YCO.0000000000000310.

Mechanisms of Melatonin in Alleviating Alzheimer's Disease

Shukla M, Govitrapong P, Boontem P, Reiter RJ, Satayavivad J.

Curr Neuropharmacol. 2017;15(7):1010-1031. doi: 10.2174/1570159X15666170313123454.

Alzheimer's disease pathology and the unfolded protein response: prospective pathways and therapeutic targets

Koss DJ, Platt B.

Behav Pharmacol. 2017 Apr;28(2 and 3-Spec Issue):161-178. doi: 10.1097/FBP.0000000000000299.